SEA
TMO icon

Stegent Equity Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Stegent Equity Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-960
Closed -$567K – 97
2022
Q1 		$567K Sell
960
-497
-34% -$286K 0.48% 51
2021
Q4 		$969K Buy
+1,457
New +$910K 0.79% 46

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stegent Equity Advisors's TMO Position: Q2 2022 in Review

Stegent Equity Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 960 shares — an estimated $567K sold.

Stegent Equity Advisors first reported a position in TMO in Q4 2021 and held it in 2 quarters. The position peaked at $969K in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Stegent Equity Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Stegent Equity Advisors sold 960 Thermo Fisher Scientific shares in Q2 2022, an estimated $567K.
  • Stegent Equity Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 2 quarters.
  • Stegent Equity Advisors's Thermo Fisher Scientific position peaked at $969K in Q4 2021.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Stegent Equity Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.